The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular and Molecular Mechanisms of Pain
Basbaum, A. I., Bautista, D. M., Scherrer, G., & Julius, D. (2009) · Cell · doi:10.1016/j.cell.2009.09.028 · Cited by 4,344
CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259
Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
Meunier, J.-C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.-L., Guillemot, J.-C., Ferrara, P., Monsarrat, B., et al. (1995) · Nature · doi:10.1038/377532a0 · Cited by 1,912
Self-citationReversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
Bergman, H., Wichmann, T., & DeLong, M. R. (1990) · Science · doi:10.1126/science.2402638 · Cited by 1,907
Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor
Reinscheid, R. K., Nothacker, H.-P., Bourson, A., Ardati, A., Henningsen, R. A., Bunzow, J. R., Grandy, D. K., Langen, H., Monsma, F. J., & Civelli, O. (1995) · Science · doi:10.1126/science.270.5237.792 · Cited by 1,821
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Differential regulation and properties of MAPKs
Raman, M., Chen, W., & Cobb, M. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210392 · Cited by 1,430 · cited 1×
“MAPK signaling has a broad array of convergent points with GPCR signaling as do the canonical cytokine pathways (Raman et al., 2007), so it is likely that the NOP-dependent stimulation of JNK and p38 MAPKs converge onto the nuclear factor kB pathways and could in turn elevate cytokine transcription.”
BackgroundCrystal structure of the µ-opioid receptor bound to a morphinan antagonist
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S. (2012) · Nature · doi:10.1038/nature10954 · Cited by 1,356
Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801
Trujillo, K. A., & Akil, H. (1991) · Science · doi:10.1126/science.1824728 · Cited by 1,210
ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localization
Mollereau, C., Parmentier, M., Mailleux, P., Butour, J.-L., Moisand, C., Chalon, P., Caput, D., Vassart, G., & Meunier, J.-C. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80235-1 · Cited by 1,077
Molecular mechanisms of opioid receptor-dependent signaling and behavior
Al-Hasani, R., & Bruchas, M. R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238bba6 · Cited by 1,067
Self-citationStructure of the human κ-opioid receptor in complex with JDTic
Wu, H., Wacker, D., Mileni, M., Katritch, V., Han, G. W., Vardy, E., Liu, W., Thompson, A. A., Huang, X.-P., Carroll, F. I., et al. (2012) · Nature · doi:10.1038/nature10939 · Cited by 879
Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study
Mansour, A., Fox, C. A., Burke, S., Meng, F., Thompson, R. C., Akil, H., & Watson, S. J. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903500307 · Cited by 870
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
Distinct functions of the two isoforms of dopamine D2 receptors
Usiello, A., Baik, J.-H., Rougé-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P. V., & Borrelli, E. (2000) · Nature · doi:10.1038/35041572 · Cited by 717
Cavanaugh, D. J., Lee, H., Lo, L., Shields, S. D., Zylka, M. J., Basbaum, A. I., & Anderson, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901507106 · Cited by 707
Structure of the δ-opioid receptor bound to naltrindole
Granier, S., Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Weis, W. I., & Kobilka, B. K. (2012) · Nature · doi:10.1038/nature11111 · Cited by 667
Structural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X.-P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 664
Bunzow, J. R., Saez, C., Mortrud, M., Bouvier, C., Williams, J. T., Low, M., & Grandy, D. K. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00561-3 · Cited by 607
Allosteric sodium in class A GPCR signaling
Katritch, V., Fenalti, G., Abola, E. E., Roth, B. L., Cherezov, V., & Stevens, R. C. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.03.002 · Cited by 511
Therapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 510
Visualization of arrestin recruitment by a G-protein-coupled receptor
Shukla, A. K., Westfield, G. H., Xiao, K., Reis, R. I., Huang, L.-Y., Tripathi-Shukla, P., Qian, J., Li, S., Blanc, A., Oleskie, A. N., et al. (2014) · Nature · doi:10.1038/nature13430 · Cited by 510
Molecular control of δ-opioid receptor signalling
Fenalti, G., Giguere, P. M., Katritch, V., Huang, X.-P., Thompson, A. A., Cherezov, V., Roth, B. L., & Stevens, R. C. (2014) · Nature · doi:10.1038/nature12944 · Cited by 497
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Thompson, A. A., Liu, W., Chun, E., Katritch, V., Wu, H., Vardy, E., Huang, X.-P., Trapella, C., Guerrini, R., Calo, G., et al. (2012) · Nature · doi:10.1038/nature11085 · Cited by 477
Self-citationDissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain
Scherrer, G., Imamachi, N., Cao, Y.-Q., Contet, C., Mennicken, F., O'Donnell, D., Kieffer, B. L., & Basbaum, A. I. (2009) · Cell · doi:10.1016/j.cell.2009.04.019 · Cited by 462
Pharmacology of nociceptin and its receptor: a novel therapeutic target
Calo', G., Guerrini, R., Rizzi, A., Salvadori, S., & Regoli, D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703219 · Cited by 437
Self-citationIon channel regulation by G proteins
Wickman, K., & Clapham, D. E. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.4.865 · Cited by 423
cDNA cloning and regional distribution of a novel member of the opioid receptor family
Fukuda, K., Kato, S., Mori, K., Nishi, M., Takeshima, H., Iwabe, N., Miyata, T., Houtani, T., & Sugimoto, T. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80603-9 · Cited by 410
Neal, C. R., Mansour, A., Reinscheid, R., Nothacker, H.-P., Civelli, O., & Watson, S. J. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990419)406:4<503::aid-cne7>3.0.co;2-p · Cited by 397
cDNA Cloning of an orphan opiate receptor gene family member and its splice variant
Wang, J. B., Johnson, P. S., Imai, Y., Persico, A. M., Ozenberger, B. A., Eppler, C. M., & Uhl, G. R. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00557-5 · Cited by 381
A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior
Vardy, E., Robinson, J. E., Li, C., Olsen, R. H. J., DiBerto, J. F., Giguere, P. M., Sassano, F. M., Huang, X.-P., Zhu, H., Urban, D. J., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.065 · Cited by 380
Orphanin FQ is a functional anti-opioid peptide
Mogil, J. S., Grisel, J. E., Reinscheid, R. K., Civelli, O., Belknap, J. K., & Grandy, D. K. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00338-7 · Cited by 375
Neal, C. R., Mansour, A., Reinscheid, R., Nothacker, H.-P., Civelli, O., Akil, H., & Watson, S. J. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19991004)412:4<563::aid-cne2>3.0.co;2-z · Cited by 356
Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress
Jenck, F., Moreau, J.-L., Martin, J. R., Kilpatrick, G. J., Reinscheid, R. K., Monsma, F. J., Nothacker, H.-P., & Civelli, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14854 · Cited by 347
Ligand binding and micro-switches in 7TM receptor structures
Nygaard, R., Frimurer, T. M., Holst, B., Rosenkilde, M. M., & Schwartz, T. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.02.006 · Cited by 346
Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward
Al-Hasani, R., McCall, J. G., Shin, G., Gomez, A. M., Schmitz, G. P., Bernardi, J. M., Pyo, C.-O., Park, S. I., Marcinkiewcz, C. M., Crowley, N. A., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.08.019 · Cited by 345
Self-citationHuang, P., Kehner, G. B., Cowan, A., & Liu-Chen, L.-Y. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29586-0 · Cited by 340
Kinase cascades and ligand-directed signaling at the kappa opioid receptor
Bruchas, M. R., & Chavkin, C. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1806-y · Cited by 317
Self-citationZhu, C.-B., Lindler, K. M., Owens, A. W., Daws, L. C., Blakely, R. D., & Hewlett, W. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.116 · Cited by 317
Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors
Manabe, T., Noda, Y., Mamiya, T., Katagiri, H., Houtani, T., Nishi, M., Noda, T., Takahashi, T., Sugimoto, T., Nabeshima, T., et al. (1998) · Nature · doi:10.1038/29073 · Cited by 310
Land, B. B., Bruchas, M. R., Schattauer, S., Giardino, W. J., Aita, M., Messinger, D., Hnasko, T. S., Palmiter, R. D., & Chavkin, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910705106 · Cited by 301
Self-citationGenetic identification of C fibres that detect massage-like stroking of hairy skin in vivo
Vrontou, S., Wong, A. M., Rau, K. K., Koerber, H. R., & Anderson, D. J. (2013) · Nature · doi:10.1038/nature11810 · Cited by 288
A mu–delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks
Erbs, E., Faget, L., Scherrer, G., Matifas, A., Filliol, D., Vonesch, J.-L., Koch, M., Kessler, P., Hentsch, D., Birling, M.-C., et al. (2015) · Brain Structure and Function · doi:10.1007/s00429-014-0717-9 · Cited by 285
Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent Dysphoria
Bruchas, M. R., Land, B. B., Aita, M., Xu, M., Barot, S. K., Li, S., & Chavkin, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3769-07.2007 · Cited by 281
Self-citationA synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat
Jenck, F., Wichmann, J., Dautzenberg, F. M., Moreau, J.-L., Ouagazzal, A. M., Martin, J. R., Lundstrom, K., Cesura, A. M., Poli, S. M., Roever, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090514397 · Cited by 275
Bruchas, M. R., Schindler, A. G., Shankar, H., Messinger, D. I., Miyatake, M., Land, B. B., Lemos, J. C., Hagan, C. E., Neumaier, J. F., Quintana, A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.011 · Cited by 267
Self-citationStructure, tissue distribution, and chromosomal localization of the prepronociceptin gene.
Mollereau, C., Simons, M. J., Soularue, P., Liners, F., Vassart, G., Meunier, J. C., & Parmentier, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8666 · Cited by 264
Molecular Cloning of a Novel G Protein‐Coupled Receptor Related to the Opiate Receptor Family
Lachowicz, J. E., Shen, Y., Monsma, F. J., & Sibley, D. R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010034.x · Cited by 256
Yoshimura, M., & Jessell, T. M. (1989) · Journal of Neurophysiology · doi:10.1152/jn.1989.62.1.96 · Cited by 253
Primary structure and tissue distribution of the orphanin FQ precursor.
Nothacker, H. P., Reinscheid, R. K., Mansour, A., Henningsen, R. A., Ardati, A., Monsma, F. J., Watson, S. J., & Civelli, O. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8677 · Cited by 253
d-Methadone Blocks Morphine Tolerance and N-Methyl-d-Aspartate-Induced Hyperalgesia
Davis, A. M., & Inturrisi, C. E. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38234-5 · Cited by 249
Nociceptin/Orphanin FQ Microinjected into Hippocampus Impairs Spatial Learning in Rats
Sandin, J., Georgieva, J., Schött, P. A., Ögren, S. O., & Terenius, L. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01367.x · Cited by 244
Scherrer, G., Tryoen-Tóth, P., Filliol, D., Matifas, A., Laustriat, D., Cao, Y. Q., Basbaum, A. I., Dierich, A., Vonesh, J.-L., Gavériaux-Ruff, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603359103 · Cited by 243
A new selective antagonist of the nociceptin receptor
Guerrini, R., Calo, G., Rizzi, A., Bigoni, R., Bianchi, C., Salvadori, S., & Regoli, D. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701640 · Cited by 238
Self-citationNicolas, L. B., Kolb, Y., & Prinssen, E. P. M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.015 · Cited by 234 · cited 2×
“…lick suppression test, isolation-induced vocalizations in rat and guinea pig pups, mouse GellerSeifter test (Varty et al., 2005), marble burying (Nicolas et al., 2006), rat Vogel conflict punished drinking test, the social approach-avoidance test in Lewis rats, novelty-induced hypophagia and…”
BackgroundMethodFunctional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ
Mogil, J. S., Grisel, J. E., Zhangs, G., Belknap, J. K., & Grandy, D. K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12917-7 · Cited by 227
Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro
Connor, M., Vaughan, C. W., Chieng, B., & Christie, M. J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16080.x · Cited by 225
Xj, X., Hao, J. ‐., & Wiesenfeld‐Hallin, Z. (1996) · PubMed · Cited by 217
Lutfy, K., Eitan, S., Bryant, C. D., Yang, Y. C., Saliminejad, N., Walwyn, W., Kieffer, B. L., Takeshima, H., Carroll, F. I., Maidment, N. T., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10331.2003 · Cited by 211
Modulation of voltage-dependent calcium channels by G proteins
Zamponi, G. W., & Snutch, T. P. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80060-3 · Cited by 209
Kawamoto, H., Ozaki, S., Itoh, Y., Miyaji, M., Arai, S., Nakashima, H., Kato, T., Ohta, H., & Iwasawa, Y. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990517p · Cited by 204
Structure-Activity Relationship Studies on the Novel Neuropeptide Orphanin FQ
Reinscheid, R. K., Ardati, A., Monsma, F. J., & Civelli, O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14163 · Cited by 202
Unifying Family A GPCR Theories of Activation
Tehan, B. G., Bortolato, A., Blaney, F. E., Weir, M. P., & Mason, J. S. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.004 · Cited by 196
Witkin, J. M., Statnick, M. A., Rorick-Kehn, L. M., Pintar, J. E., Ansonoff, M., Chen, Y., Tucker, R. C., & Ciccocioppo, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.011 · Cited by 194
G Protein–Coupled Receptor Deorphanizations
Civelli, O., Reinscheid, R. K., Zhang, Y., Wang, Z., Fredriksson, R., & Schiöth, H. B. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134548 · Cited by 193
Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist
Calo', G., Guerrini, R., Bigoni, R., Rizzi, A., Marzola, G., Okawa, H., Bianchi, C., Lambert, D. G., Salvadori, S., & Regoli, D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703169 · Cited by 190
Self-citationOpiate receptor binding affected differentially by opiates and opioid peptides
Childers, S. R., Creese, I., Snowman, A. M., & Snyder, S. H. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90142-0 · Cited by 186
NG-Nitro-L-arginine prevents morphine tolerance
Kolesnikov, Y. A., Pick, C. G., & Pasternak, G. W. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90732-j · Cited by 180
Neumann, S., Braz, J. M., Skinner, K., Llewellyn-Smith, I. J., & Basbaum, A. I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1259-08.2008 · Cited by 175
Vaughan, C. W., Ingram, S. L., & Christie, M. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-00996.1997 · Cited by 174
Murphy, N. P., Ly, H. T., & Maidment, N. T. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00322-3 · Cited by 173
Kuzmin, A., Sandin, J., Terenius, L., & Ögren, S. O. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041350 · Cited by 173
Bohn, L. M., Dykstra, L. A., Lefkowitz, R. J., Caron, M. G., & Barak, L. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.106 · Cited by 171
ORL1 receptor–mediated internalization of N-type calcium channels
Altier, C., Khosravani, H., Evans, R. M., Hameed, S., Peloquin, J. B., Vartian, B. A., Chen, L., Beedle, A. M., Ferguson, S. S. G., Mezghrani, A., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1605 · Cited by 170
Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene.
Min, B. H., Augustin, L. B., Felsheim, R. F., Fuchs, J. A., & Loh, H. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9081 · Cited by 169
Ozaki, S., Kawamoto, H., Itoh, Y., Miyaji, M., Azuma, T., Ichikawa, D., Nambu, H., Iguchi, T., Iwasawa, Y., & Ohta, H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00520-3 · Cited by 168
Cebranopadol: A Novel Potent Analgesic Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist
Linz, K., Christoph, T., Tzschentke, T. M., Koch, T., Schiene, K., Gautrois, M., Schröder, W., Kögel, B. Y., Beier, H., Englberger, W., et al. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213694 · Cited by 168
Orphanin FQ/Nociceptin Modulation of Mesolimbic Dopamine Transmission Determined by Microdialysis
Murphy, N. P., & Maidment, N. T. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730179.x · Cited by 167
Ciccocioppo, R., Economidou, D., Fedeli, A., Angeletti, S., Weiss, F., Heilig, M., & Massi, M. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1645-1 · Cited by 166
Calo, G., Rizzi, A., Rizzi, D., Bigoni, R., Guerrini, R., Marzola, G., Marti, M., McDonald, J., Morari, M., Lambert, D. G., et al. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704706 · Cited by 164
Self-citationDooley, C. T., Spaeth, C. G., Berzetei-Gurske, I. P., Craymer, K., Adapa, I. D., Brandt, S. R., Houghten, R. A., & Toll, L. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37095-8 · Cited by 160
Self-citationZiconotide: a clinical update and pharmacologic review
Pope, J. E., & Deer, T. R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.784269 · Cited by 159
A Cellular Mechanism for the Bidirectional Pain-Modulating Actions of Orphanin FQ/Nociceptin
Pan, Z. Z., Hirakawa, N., & Fields, H. L. (2000) · Neuron · doi:10.1016/s0896-6273(00)81183-6 · Cited by 158
Orphanin FQ/nociceptin blocks acquisition of morphine place preference
Murphy, N. P., Lee, Y., & Maidment, N. T. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01425-0 · Cited by 158
Bardoni, R., Tawfik, V. L., Wang, D., François, A., Solórzano, C., Shuster, S. A., Choudhury, P., Betelli, C., Cassidy, C., Smith, K., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.044 · Cited by 156
Dourish, C. T., Hawley, D., & Iversen, S. D. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90183-5 · Cited by 155
Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling
Melief, E. J., Miyatake, M., Bruchas, M. R., & Chavkin, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000751107 · Cited by 154
Self-citationDragicevic, E., Schiemann, J. M., & Liss, B. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.037 · Cited by 153
Challenges for opioid receptor nomenclature: IUPHAR Review 9
Cox, B. M., Christie, M. J., Devi, L. A., Toll, L., & Traynor, J. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12612 · Cited by 151
Self-citationAgonist-independent modulation of N-type calcium channels by ORL1 receptors
Beedle, A. M., McRory, J. E., Poirot, O., Doering, C. J., Altier, C., Barr�re, C., Hamid, J., Nargeot, J., Bourinet, E., & Zamponi, G. W. (2004) · Nature Neuroscience · doi:10.1038/nn1180 · Cited by 149
Guanine nucleotides differentiate agonist and antagonist interactions with opiate receptors
Childers, S. R., & Snyder, S. H. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90077-2 · Cited by 148
Zaratin, P., Petrone, G., Sbacchi, M., Garnier, M. J., Fossati, C., Petrillo, P., Ronzoni, S., Giardina, G. A. M., & Scheideler, M. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055848 · Cited by 147
Spatiotemporal Control of Opioid Signaling and Behavior
Siuda, E. R., Copits, B. A., Schmidt, M. J., Baird, M. A., Al‐Hasani, R., Planer, W., Funderburk, S. C., McCall, J. G., Gereau, R. W., & Bruchas, M. R. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.066 · Cited by 146
Self-citationThe novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion
Devine, D. P., Reinscheid, R. K., Monsma, F. J., Civelli, O., & Akil, H. (1996) · Brain Research · doi:10.1016/0006-8993(96)00476-3 · Cited by 145
Effect of nociceptin/orphanin FQ on the rewarding properties of morphine
Ciccocioppo, R., Angeletti, S., Sanna, P. P., Weiss, F., & Massi, M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00590-2 · Cited by 142
Ueda, H., Yamaguchi, T., Tokuyama, S., et al. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00832-x · Cited by 138
Nociceptin stimulates locomotion and exploratory behaviour in mice
Florin, S., Suaudeau, C., Meunier, J., & Costentin, J. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00707-8 · Cited by 138
Peluso, J., LaForge, K. S., Matthes, H. W. D., et al. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00178-1 · Cited by 137
Dextromethorphan attenuates and reverses analgesic tolerance to morphine
Elliott, K. J., Hynansky, A., & Inturrisi, C. E. (1994) · Pain · doi:10.1016/0304-3959(94)90022-1 · Cited by 136
Yamamoto, T., Nozaki‐Taguchi, N., & Kimura, S. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00166-8 · Cited by 133
Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo
Stanfa, L. C., Chapman, V., Kerr, N., & Dickenson, A. H. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15618.x · Cited by 132
Effect of nociceptin on alcohol intake in alcohol-preferring rats
Ciccocioppo, R., Panocka, I., Polidori, C., Regoli, D. C., & Massi, M. (1999) · Psychopharmacology · doi:10.1007/s002130050828 · Cited by 130
Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?
Zaki, P. A., Keith, D. E., Brine, G. A., Carroll, F. I., & Evans, C. J. (2000) · PubMed · Cited by 129
Schröder, W., Lambert, D. G., Ko, M., & Koch, T. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12744 · Cited by 128
Gavioli, E. C., Marzola, G., Guerrini, R., Bertorelli, R., Zucchini, S., de Lima, T. C. M., Rae, G. A., Salvadori, S., Regoli, D. C., & Calò, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02603.x · Cited by 125
Marti, M., Mela, F., Fantin, M., Zucchini, S., Brown, J. M., Witta, J., Benedetto, M. D., Búzás, B., Reinscheid, R. K., Salvadori, S., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2546-05.2005 · Cited by 122
Self-citationEconomidou, D., Hansson, A. C., Weiss, F., Terasmaa, A., Sommer, W. H., Cippitelli, A., Fedeli, A., Martin-Fardon, R., Massi, M., Ciccocioppo, R., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.02.004 · Cited by 120
Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system
Schlicker, E., & Morari, M. (2000) · Peptides · doi:10.1016/s0196-9781(00)00233-3 · Cited by 118
Sakoori, K., & Murphy, N. P. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1643-3 · Cited by 117
Hao, J., Xu, I. S., Wiesenfeld‐Hallin, Z., & Xu, X. (1998) · Pain · doi:10.1016/s0304-3959(98)00071-2 · Cited by 117
Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus
Yu, T., Fein, J. A., Phan, T., Evans, C. J., & Xie, C.-W. (1997) · Hippocampus · doi:10.1002/(sici)1098-1063(1997)7:1<88::aid-hipo9>3.0.co;2-3 · Cited by 113
Modulation of Ca2+ channel currents of acutely dissociated rat periaqueductal grey neurons
Connor, M. A., & Christie, M. J. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.047bo.x · Cited by 113
Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ
Morgan, M. M., Grisel, J. E., Robbins, C. S., & Grandy, D. K. (1997) · Neuroreport · doi:10.1097/00001756-199711100-00003 · Cited by 112
Relative Reinforcing Effects of Three Opioids with Different Durations of Action
Ko, M., Terner, J. M., Hursh, S. R., Woods, J. H., & Winger, G. D. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.698 · Cited by 109
Post, A., Smart, T. S., Krikke-Workel, J., Dawson, G. R., Harmer, C. J., Browning, M. D., Jackson, K. A., Kakar, R., Mohs, R. C., Statnick, M. A., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.348 · Cited by 109
Xie, X., Wisor, J. P., Hara, J., Crowder, T. L., LeWinter, R. D., Khroyan, T. V., Yamanaka, A., Diano, S., Horváth, T. L., Sakurai, T., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35115 · Cited by 108
Self-citationMolecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
Heiman, M., Heilbut, A. M., Francardo, V., Kulicke, R., Fenster, R. J., Kolaczyk, E. D., Mesirov, J. P., Surmeier, D. J., Cenci, M. A., & Greengard, P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401819111 · Cited by 106
UFP‐101, a Peptide Antagonist Selective for the Nociceptin/Orphanin FQ Receptor
Calò, G., Guerrini, R., Rizzi, A., Salvadori, S., Burmeister, M. A., Kapusta, D. R., Lambert, D. G., & Regoli, D. C. (2005) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00264.x · Cited by 105
Advances in non-dopaminergic treatments for Parkinson's disease
Stayte, S., & Vissel, B. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00113 · Cited by 105
Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor
Bloms‐Funke, P., Gillen, C., Schuettler, A. J., & Wnendt, S. (2000) · Peptides · doi:10.1016/s0196-9781(00)00252-7 · Cited by 103
The hyperphagic effect of nociceptin/orphanin FQ in rats.
Polidori, C., CARO, G. D., & Massi, M. (2000) · Peptides · doi:10.1016/s0196-9781(00)00243-6 · Cited by 102
Cremeans, C. M., Gruley, E., Kyle, D. J., & Ko, M. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194308 · Cited by 102
Nociceptin/orphanin FQ receptor ligands
Calo’, G., Bigoni, R., Rizzi, A., et al. (2000) · Peptides · doi:10.1016/s0196-9781(00)00230-8 · Cited by 101
Self-citationNociceptin/Orphanin FQ and Its Receptor—Potential Targets for Pain Therapy?
Zeilhofer, H. U., & Calò, G. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046979 · Cited by 101
Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury
Briscini, L., Corradini, L., Ongini, E., & Bertorelli, R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01833-2 · Cited by 99
Spagnolo, B., Carrà, G., Fantin, M., Fischetti, C., Hebbes, C. P., McDonald, J. L., Barnes, T. A., Rizzi, A., Trapella, C., Fanton, G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116764 · Cited by 99
Dautzenberg, F. M., Wichmann, J., Higelin, J., Py-Lang, G., Kratzeisen, C., Malherbe, P., Kilpatrick, G. J., & Jenck, F. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29443-x · Cited by 99
Ciccocioppo, R., Economidou, D., Rimondini, R., Sommer, W. H., Massi, M., & Heilig, M. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.006 · Cited by 98
Evans, R. M., You, H., Hameed, S., Altier, C., Mezghrani, A., Bourinet, E., & Zamponi, G. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.040634 · Cited by 98
Pharmacological profiles of a novel opioid receptor‐like1 (ORL1) receptor antagonist, JTC‐801
Yamada, H., Nakamoto, H., Suzuki, Y., Ito, T., & Aisaka, K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704478 · Cited by 98
Ko, M., Woods, J. H., Fantegrossi, W. E., Galuska, C. M., Wichmann, J., & Prinssen, E. P. M. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.33 · Cited by 97
Lutfy, K., Do, T., & Maidment, N. T. (2001) · Psychopharmacology · doi:10.1007/s002130000609 · Cited by 97
Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs
Gavioli, E. C., & Calò, G. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.008 · Cited by 97
Nociceptin/orphanin FQ and opioid receptor‐like receptor mRNA expression in dopamine systems
Norton, C. S., Neal, C. R., Kumar, S., Akil, H., & Watson, S. J. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10154 · Cited by 95
Autoradiographic localization of [3H]nociceptin binding sites in the rat brain
Florin, S., Meunier, J., & Costentin, J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02669-x · Cited by 94
Agonistic Effect of Buprenorphine in a Nociceptin/OFQ Receptor-Triggered Reporter Gene Assay
Wnendt, S., Krüger, T., Janocha, E., Hildebrandt, D., & Englberger, W. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.334 · Cited by 94
Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation
Andoh, T., Itoh, M., & Kuraishi, Y. (1997) · Neuroreport · doi:10.1097/00001756-199708180-00028 · Cited by 88
Varty, G. B., Hyde, L. A., Hodgson, R. A., Lu, S. X., McCool, M. F., Kazdoba, T. M., Vecchio, R. A. D., Guthrie, D. H., Pond, A. J., Grzelak, M. E., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0041-4 · Cited by 87
Increased Nociceptive Sensitivity and Nociceptin/Orphanin FQ Levels in a Rat Model of PTSD
Zhang, Y., Gandhi, P. R., & Standifer, K. M. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-76 · Cited by 87
Kuzmin, A. V., Kreek, M. J., Bakalkin, G. Y., & Liljequist, S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301169 · Cited by 85
Redrobe, J. P., Calò, G., Regoli, D. C., & Quirion, R. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-001-0511-0 · Cited by 85
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands
Gavioli, E. C., & Calò, G. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0035-8 · Cited by 85
Antinociceptive Effects of Nociceptin/Orphanin FQ Administered Intrathecally in Monkeys
Ko, M., & Naughton, N. N. (2009) · Journal of Pain · doi:10.1016/j.jpain.2008.11.006 · Cited by 85
Toll, L., Khroyan, T. V., Polgar, W. E., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157446 · Cited by 84
Self-citationKotlinska, J. H., Wichmann, J., Łęgowska, A., Rolka, K., & Silberring, J. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200205000-00006 · Cited by 83
Highly Potent Nociceptin Analog Containing the Arg-Lys Triple Repeat
Okada, K., Sujaku, T., Chuman, Y., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3822 · Cited by 81
Shoblock, J. R., Wichmann, J., & Maidment, N. T. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.008 · Cited by 81
Khroyan, T. V., Polgar, W. E., Jiang, F., Zaveri, N. T., & Toll, L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.156711 · Cited by 81
Self-citationVarty, G. B., Lu, S. X., Morgan, C. A., Cohen-Williams, M. E., Hodgson, R. A., Smith‐Torhan, A., Zhang, H., Fawzi, A. B., Graziano, M. P., Ho, G. D., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136937 · Cited by 81
Molecular modelling of the ORL1 receptor and its complex with nociceptin
Topham, C. M., Moulédous, L., Poda, G. I., et al. (1998) · Protein Engineering Design and Selection · doi:10.1093/protein/11.12.1163 · Cited by 81
Pan, Y., Bolan, E. A., & Pasternak, G. W. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02258-1 · Cited by 80
Presynaptic effects of levodopa and their possible role in dyskinesia
Mosharov, E. V., Borgkvist, A., & Sulzer, D. (2014) · Movement Disorders · doi:10.1002/mds.26103 · Cited by 79
Marti, M., Trapella, C., Viaro, R., & Morari, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4346-06.2007 · Cited by 79
Rizzi, A., Gavioli, E. C., Marzola, G., Spagnolo, B., Zucchini, S., Ciccocioppo, R., Trapella, C., Regoli, D. C., & Calò, G. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116780 · Cited by 79
Cruz, M. T., Herman, M. A., Kallupi, M., & Roberto, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.032 · Cited by 78
Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization
Ozawa, A., Brunori, G., Mercatelli, D., Wu, J., Cippitelli, A., Zou, B., Xie, X., Williams, M., Zaveri, N. T., Low, S. A., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5122-14.2015 · Cited by 77
Self-citationCardiovascular Effects of Nociceptin in Unanesthetized Mice
Madeddu, P., Salis, M. B., Milia, A. F., et al. (1999) · Hypertension · doi:10.1161/01.hyp.33.3.914 · Cited by 77
Zhao, Z.-Q., Gao, Y., Sun, Y.-G., Zhao, C., Gereau, R. W., & Chen, Z. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705740104 · Cited by 77
Determination of activity for nociceptin in the mouse vas deferens
Berzetei‐Gurske, I. P., Schwartz, R. W., & Toll, L. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00238-5 · Cited by 75
Self-citationThe Nociceptin/Orphanin FQ Receptor (NOP) as a Target for Drug Abuse Medications
Zaveri, N. T. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795371341 · Cited by 75
Self-citationRizzi, A., Spagnolo, B., Wainford, R. D., et al. (2007) · Peptides · doi:10.1016/j.peptides.2007.04.020 · Cited by 74
Cellular neurophysiological actions of nociceptin/orphanin FQ
Moran, T. D., Abdulla, F. A., & Smith, P. A. (2000) · Peptides · doi:10.1016/s0196-9781(00)00235-7 · Cited by 74
Wang, H., Hsu, C., Huang, P., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02921.x · Cited by 73
Post, A., Smart, T. S., Krikke-Workel, J., Dawson, G. R., Harmer, C. J., Browning, M. D., Jackson, K. A., Kakar, R., Mohs, R. C., Statnick, M. A., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.78 · Cited by 72
Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function
Higgins, G. A., Grottick, A. J., Ballard, T. M., Richards, J. G., Messer, J., Takeshima, H., Pauly-Evers, M., Jenck, F., Adam, G., & Wichmann, J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00048-x · Cited by 71
[3h]-nociceptin ligand-binding and nociceptin opioid receptor mrna expression in the human brain
Berthele, A., Platzer, S., Dworzak, D., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00484-6 · Cited by 71
Ligand-Induced Changes in Surface μ-Opioid Receptor Number: Relationship to G Protein Activation?
Zaki, P. A., Keith, D. E., Brine, G. A., Carroll, F. I., & Evans, C. J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35398-4 · Cited by 70
Zhang, Y., Simpson‐Durand, C., & Standifer, K. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12701 · Cited by 69
Morgan, M. M., FOSSUM, E., LEVINE, C., & Ingram, S. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.08.003 · Cited by 69
Zhang, Z., Xin, S., Wu, G., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731502.x · Cited by 69
[Nphe1]nociceptin-(1–13)-NH2 antagonizes nociceptin effects in the mouse colon
Rizzi, A., Bigoni, R., Calò, G., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00730-x · Cited by 69
Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat
Obara, I., Przewłocki, R., & Przewłocka, B. (2005) · Pain · doi:10.1016/j.pain.2005.03.012 · Cited by 69
Ko, M., Wei, H., Woods, J. H., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106120 · Cited by 68
Endogenous Orphanin FQ/Nociceptin Is Involved in the Development of Morphine Tolerance
Chung, S., Pohl, S., Zeng, J., Civelli, O., & Reinscheid, R. K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103960 · Cited by 66
Depner, U. B., Reinscheid, R. K., Takeshima, H., Brune, K., & Zeilhofer, H. U. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02676.x · Cited by 64
Inhibitory effect of nociceptin on [3H]‐5‐HT release from rat cerebral cortex slices
Siniscalchi, A., Rodi, D., Beani, L., & Bianchi, C. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702793 · Cited by 63
The nociceptin (ORL1) receptor: molecular cloning and functional architecture
Meunier, J., Moulédous, L., & Topham, C. M. (2000) · Peptides · doi:10.1016/s0196-9781(00)00225-4 · Cited by 63
Kotlinska, J. H., Rafalski, P., Biała, G., Dyląg, T., Rolka, K., & Silberring, J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02081-8 · Cited by 62
Rutten, K., Vry, J. D., Bruckmann, W., & Tzschentke, T. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.07.036 · Cited by 62
Fu, X., Zhu, Z.-H., Wang, Y., & Wu, G. C. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.016 · Cited by 61
Arduin, M., Spagnolo, B., Calò, G., Guerrini, R., Carrà, G., Fischetti, C., Trapella, C., Marzola, E., McDonald, J. L., Lambert, D. G., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.026 · Cited by 61
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies
Rizzi, A., Molinari, S., Marti, M., Marzola, G., & Calo’, G. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.010 · Cited by 60
Self-citationBridge, K. E., Wainwright, A., Reilly, K., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00927-2 · Cited by 60
Khroyan, T. V., Polgar, W. E., Orduna, J. M., Montenegro, J., Jiang, F., Zaveri, N. T., & Toll, L. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184663 · Cited by 60
Self-citationMoretti, M., Budni, J., Freitas, A. E., Neis, V. B., Ribeiro, C. M., Balen, G. O., Rieger, D. K., Leal, R. B., & Rodrigues, A. L. S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.006 · Cited by 58
Sandin, J., Ögren, S. O., & Terenius, L. Y. (2003) · Brain Research · doi:10.1016/j.brainres.2003.11.008 · Cited by 58
Pharmacological Profile Of Nociceptin/Orphanin Fq Receptors
Calò, G., Rizzi, A., Bigoni, R., Guerrini, R., Salvadori, S., & Regoli, D. C. (2002) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2002.03633.x · Cited by 58
Reiss, D. J., Wichmann, J., Tekeshima, H., Kieffer, B. L., & Ouagazzal, A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.10.031 · Cited by 55
Lambert, D. G., Bird, M. F., & Rowbotham, D. J. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu332 · Cited by 55
Morphine tolerance and dependence in nociceptin/orphanin fq transgenic knock-out mice
Kest, B., Hopkins, E., Palmese, C. A., Chen, Z. P., Mogil, J. S., & Pintar, J. E. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00037-9 · Cited by 54
Donica, C. L., Awwad, H. O., Thakker, D. R., et al. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.084632 · Cited by 54
Malfacini, D., Ambrosio, C., Grò, M. C., Sbraccia, M., Trapella, C., Guerrini, R., Bonora, M., Pinton, P., Costa, T., & Calò, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132865 · Cited by 53
Shoblock, J. R. (2007) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2007.00007.x · Cited by 52
Berger, B., Rothmaier, A. K., Wedekind, F., Zentner, J., Feuerstein, T. J., & Jackisch, R. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706782 · Cited by 51
Mittal, N., Roberts, K., Pal, K., Bentolila, L. A., Fultz, E. K., Minasyan, A., Cahill, C. M., Pradhan, A. A. A., Conner, D. A., DeFea, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.015 · Cited by 51
The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine
Marquez, P. V., Nguyen, A. T., Hamid, A., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.11.003 · Cited by 51
Orphanin FQ/nociceptin blocks methamphetamine place preference in rats
Zhao, R., Woo, R., Jeong, M.-S., Shin, B., Kim, D.-G., & Kim, K.-W. (2003) · Neuroreport · doi:10.1097/00001756-200312190-00019 · Cited by 51
Olianas, M. C., Dedoni, S., Boi, M., & Onali, P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05629.x · Cited by 50
Ding, H., Hayashida, K., Suto, T., Sukhtankar, D. D., Kimura, M., Mendenhall, V., & Ko, M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13124 · Cited by 50
Loss of Morphine Reward and Dependence in Mice Lacking G Protein–Coupled Receptor Kinase 5
Glück, L., Loktev, A., Moulédous, L., Mollereau, C., Law, P., & Schulz, S. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.021 · Cited by 50
Cited by
Endogenous and Exogenous Opioids in Pain
Corder, G., Castro, D. C., Bruchas, M. R., & Scherrer, G. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061522 · Cited by 502
Self-citationOpioid-induced hyperalgesia: Cellular and molecular mechanisms
Roeckel, L.-A., Le Coz, G.-M., Gavériaux-Ruff, C., & Simonin, F. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.029 · Cited by 388
Opioid receptors: drivers to addiction?
Darcq, E., & Kieffer, B. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0028-x · Cited by 352
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Opioid-Induced Tolerance and Hyperalgesia
Mercadante, S., Arcuri, E., & Santoni, A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00660-0 · Cited by 326
Metadata
- Authors
- Toll, L., Bruchas, M. R., Calo', G., Cox, B. M., & Zaveri, N. T.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 68
- Issue
- 2
- Pages
- 419-457
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2304450774
- Cited by
- 297
- References
- 274
- FWCI
- 18.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.